Thomas A. Einhorn, M.D. is Professor of Orthopedic Surgery at New York University School of Medicine and Director of Clinical and Translational Research Development at NYU Langone Medical Center, Hospital for Joint Diseases.

A graduate of Rutgers University and Cornell Medical College, he completed his internship at the Hospital of the University of Pennsylvania, orthopaedic residency at St. Luke's - Roosevelt Hospital in New York City, and a fellowship at the Hospital for Special Surgery. His professional interests include research on the repair and regeneration of bone and cartilage, reconstructive surgery of the hip and knee, and the treatment of metabolic bone disease. He has served as Chairman of the Orthopaedics and Musculoskeletal Study Section of the National Institutes of Health, President of the Orthopaedic Research Society, President of the International Society for Fracture Repair and Chairman of both the Committee on Examinations and the Council on Research and Scientific Affairs of the American Academy of Orthopaedic Surgeons. Currently, he serves on the Board of Trustees of the Orthopaedic Research and Education Foundation and the National Osteoporosis Foundation.

His awards include the Marshall R. Urist Award and the Alfred R. Shands, Jr. Award from the Orthopaedic Research Society, the Kappa Delta Award from the American Academy of Orthopaedic Surgeons, the Dr. Marian Ropes Physician Achievement Award from the Arthritis Foundation and the Marshall Schiff Award from the American College of Rheumatology. He is Deputy Editor for Current Concepts Reviews for The Journal of Bone and Joint Surgery, and serves on the Editorial Boards of The Journal of Bone and Mineral Research, Journal of Orthopaedic Research and Bone. An author of over 200 peer-reviewed articles, his career goals are dedicated to exploring the role of molecular medicine in orthopaedic surgery.

Since 1982, Dr. Einhorn has practiced as a leading surgeon specializing in reconstructive surgery of the hip and knee in Boston and New York. He is an internationally acclaimed leader in the field of regenerative medicine, an area heralded as the future of orthopaedics. One of Dr. Einhorn's specialties is Orthopaedic Adult Stem Cell Surgery for Avascular Necrosis of the Hip. His innovative, safe technique, which has been practiced by only a few doctors nationwide, grows new bone utilizing the patient's own stem cells procured from bone marrow for restoration of function and pathology of hip joints.

Dr. Einhorn's research has been funded by the National Institutes of Health since 1990. Working closely with a team of 50 physicians and scientists, including orthopaedic surgeons, Ph.D. scientists, graduate students, orthopaedic doctors in training, nurse practitioners, and post doctorate fellows, Dr. Einhorn researches and develops new therapies to enhance the repair of bone, and the blood supply to bone.